. . . . . . . . . "ONGENTYS is indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing “off” episodes" . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCC0CnI6yMUipkXh7RB8b/9rRnO8+qDR+pJVf//jGV0r2nd7JcvWFkhPN/eLja/pUw/+nvTE24rhKqK/jWxppJLoka+bk57wrYw43DrSbzQWoJc3ImWe3d08jSYt3mh3uOLWKciogBaonJUBohJsqhTmOULevIPONTZOMzeOJTWwQIDAQAB" . "gRorF/ryw90FGG6no/aNeNZRcCM06PW+ji+tecpLO1yxYhzhXXTlafj/4hl6RqSjocMoDKyfuJ3QAgOsTLSPQfWuYlA3DKTPmbn0ELmkl/VUovX7935cBWMAbKhkTki104umtUw4y9SrBX002l5IZkJb7F+z2QcEwyEwQe6wOhk=" . . "2021-04-04T22:49:27.940+02:00"^^ . . . . .